Compare BIO-TECHNE Corp (TECH) vs iShares 10 20 Year Treasury Bond ETF (TLH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BIO-TECHNE Corp vs iShares 10 20 Year Treasury Bond ETF — how do they compare? BIO-TECHNE Corp trades at $72.46 (market cap $11.36B), while iShares 10 20 Year Treasury Bond ETF trades at $92.19 (market cap $11.02B). The key difference: BIO-TECHNE Corp and iShares 10 20 Year Treasury Bond ETF are close in size by market cap, and BIO-TECHNE Corp pays a 0.44% dividend while iShares 10 20 Year Treasury Bond ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold BIO-TECHNE Corp for 63 Days and iShares 10 20 Year Treasury Bond ETF for 62 Days on average.
| TECH | TLH | |
|---|---|---|
Market Cap | $11.36B | $11.02B |
Volume | 5,390,331 | 6,609,157 |
Sector | Health | Fixed Income |
52-Week High | $72.61 | $105.36 |
52-Week Low | $43.31 | $91.34 |
Typical Hold Time | 63 Days | 62 Days |
Enterprise Value | $11.39B | — |
Dividend Yield | 0.44% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TECH trades at $72.53, near its 52-week high of $72.70, with a bullish technical signal from moving averages. The company reported mixed quarterly earnings, beating in Q4 2025 and Q2 2026 but missing in Q1 2026. Revenue for 2025 was $1.22B, with a net income margin of 14.97%. Valuation ratios are elevated, with a P/E of 62.46 and P/S of 9.36. A significant development is the shareholder-approved acquisition by Merck KGaA at $73.00 per share, pending completion.
The outlook is heavily influenced by the pending acquisition, offering a near-term price ceiling. Fundamentals show solid profitability but high valuation multiples. Risks include acquisition deal completion uncertainty and integration challenges. Analyst sentiment is mixed with no sell ratings, but the consensus price target of $65.78 suggests limited upside from current levels, making the stock a hold pending acquisition closure.
TLH (iShares 10-20 Year Treasury Bond ETF) is trading at $91.45, down 0.12% with a bearish technical signal. The ETF shows unusually high trading volume and faces pressure from rising Treasury yields, which reached multi-decade highs recently. Dividend distributions continue with recent payments of $0.36-$0.38 per share, but key valuation ratios remain unavailable for analysis.
The outlook remains challenging as bond markets face persistent yield pressures from inflation concerns and Fed policy uncertainty. Investment opportunity exists for yield-seeking investors, but risks include continued bond market volatility and potential further yield increases that could pressure ETF prices lower.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →About iShares 10 20 Year Treasury Bond ETF
TLH tracks the ICE U.S. Treasury 10-20 Year Bond Index, offering targeted exposure to intermediate-to-long term government debt. It serves as a middle ground between the 7-10 year (IEF) and 20+ year (TLT) ETFs, balancing yield and duration risk.
Read more on TLH →
